SERTAD3 Activators
SERTAD3 employ a variety of signaling pathways to modulate its functional activity within cells. Epidermal Growth Factor (EGF) engages the EGFR pathway, which is known to trigger downstream signaling cascades that can lead to the activation of transcription factors and co-factors with which SERTAD3 interacts. This interaction promotes the functional activation of SERTAD3, enabling it to participate more actively in cellular transcription processes. Forskolin, by elevating intracellular cAMP levels through the activation of adenylate cyclase, also indirectly fosters an environment conducive to the functional activation of SERTAD3. The increased cAMP activates protein kinase A (PKA), which can lead to the phosphorylation of transcriptional regulators that may interact with SERTAD3, thereby facilitating its functional role.
Phorbol 12-myristate 13-acetate (PMA) and Ionomycin contribute to the activation of SERTAD3 through the modulation of protein kinase C (PKC) and calcium-sensitive pathways, respectively. PMA can activate PKC, which subsequently phosphorylates transcription factors that work in concert with SERTAD3, thereby enabling its functional activation. Ionomycin, through its capacity to increase the intracellular calcium concentration, activates pathways that can lead to the cooperative interaction between calcium-responsive transcription factors and SERTAD3. Other compounds such as Insulin and Hydrogen Peroxide trigger signaling pathways like PI3K/Akt and redox-sensitive cascades, respectively, which can modify transcription factors and co-factors that interact with SERTAD3. Similarly, Dibutyryl-cAMP (db-cAMP), as a stable cAMP analog, activates PKA, which then can target transcriptional co-factors that associate with SERTAD3, enhancing its transcriptional co-activation. Retinoic Acid and 1,25-Dihydroxyvitamin D3 exert their effects through binding to nuclear receptors, which then interact with DNA and potentially with SERTAD3, leading to its activation. Lastly, agents such as Trichostatin A and 5-Azacytidine, by altering the chromatin structure through inhibition of histone deacetylases and DNA methyltransferases, respectively, create a genomic landscape that can facilitate the binding and activation of SERTAD3, while Anisomycin's activation of MAPK signaling can phosphorylate transcription factors associated with SERTAD3, promoting its functional activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate transcription factors that work in concert with SERTAD3, leading to its functional activation through cooperative interaction at promoter binding sites. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentration, leading to the activation of calcium-sensitive signaling pathways. These pathways can activate transcription factors that work synergistically with SERTAD3, resulting in its functional activation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway, which can lead to the activation of downstream transcription factors and co-factors that SERTAD3 may interact with, culminating in the functional activation of SERTAD3. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen Peroxide acts as a signaling molecule to activate redox-sensitive pathways, which can modify transcription factors and co-factors that SERTAD3 interacts with, leading to its functional activation via oxidative stress response elements. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that activates PKA. PKA can phosphorylate transcription regulators that associate with SERTAD3, resulting in the functional activation of SERTAD3 through enhanced transcriptional co-activation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid binds to retinoic acid receptors (RARs), which can dimerize with retinoid X receptors (RXRs) and bind to DNA, influencing transcriptional activities. SERTAD3 may interact with these transcription complexes, leading to its functional activation. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
1,25-Dihydroxyvitamin D3 binds to the vitamin D receptor (VDR), which forms a heterodimer with RXR and binds to vitamin D response elements (VDREs) in DNA, potentially interacting with and activating SERTAD3 in the process. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases (HDACs), which increases acetylation of histones, leading to a more open chromatin structure. This can enhance the access of transcription factors and co-factors that SERTAD3 interacts with, thereby resulting in the functional activation of SERTAD3. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferases, leading to hypomethylation of DNA and potentially affecting gene expression patterns. This could create a more favorable context for the binding and functional activation of SERTAD3 in gene transcription. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate MAPK signaling pathways, which may result in the phosphorylation of transcription factors that associate with SERTAD3, thereby leading to its functional activation through enhanced transcriptional co-activation. | ||||||